Jobs
-
US-based AirWare Labs says that it has filed patent applications for an intranasal drug delivery system that will include “AirWare Labs’ patent-pending disposable sealed cartridge and patent-pending nasal insert system with insufflation plugins, both of… Read more . . .
-
The US Patent and Trademark Office (USPTO) has awarded US Patent No 8,883,728, “Intranasal administration of active agents to the central nervous system,” to Aegis Therapeutics, the company said. The patent covers, “Pharmaceutical compositions and… Read more . . .
-
The Bill and Melinda Gates Foundation has awarded a $2.5 million grant to researchers at Liverpool School of Tropical Medicine (LSTM) for a study to determine the effects of nasal spray flu vaccine on pneumococcal… Read more . . .
-
According to Avanir Pharmaceuticals,the FDA has issued a Discipline Review letter in response to the company’s NDA for AVP-825 intranasal dry powder sumatriptan requesting that the company “optimize the product-user interface” and conduct additional human… Read more . . .
-
The Australian Research Council has awarded a $521,800 grant to Daniela Traini and Paul Young of the Woolcock Institute’s RespiTech group and Patrick Spicer of the University of New South Wales for development of inhalable… Read more . . .
-
As AstraZeneca completes the acquisition of Almirall’s respiratory drug franchise, which was first announced in July 2014, Almirall says that 719 employees will transfer to AstraZeneca. The deal includes the inhalation R&D company Almirall Sofotec… Read more . . .
-
Impax Laboratories has reported a 19.1% increase in total revenues for the quarter ended September 30, 2014 compared to the third quarter of the prior year. The company attributes a portion of the increase in… Read more . . .
-
Danish instrument manufacturer Ametek Test & Calibration Instruments says that it has worked with “a leading pharmaceutical manufacturer” to develop a semi-automated tester that “detects the firing load and valve breakdown load of one-shot, pressurized… Read more . . .
-
Accordig to Sandoz, the company has received marketing authorization in Estonia, Latvia and Lithuania for the 50-250 and 50-500 µg dosages of the AirFluSal Forspiro salmeterol/fluticasone DPI for the treatment of asthma and COPD. The… Read more . . .
-
Bristol-Myers Squibb could pay a total of up to $444 million to acquire Galecto Biotech and its TD139 inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), plus potential milestones. The newly announced… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA